SCHEMBL5030745

SCHEMBL5030745

Cc1cnccc1C(=O)Nc1ccc(-c2sc(N3CCOCC3)nc2C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 2/20 0.46
GAA P10253 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 1/20 0.46
CYP1A2 P05177 1/20 0.46
IRAK4 Q9NWZ3 1/20 0.45
MAPT P10636 5/20 0.44
FLT1 P17948 1/20 0.44
KDR P35968 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TP53 P04637 2/20 0.44
RAB9A P51151 2/20 0.44
THRB P10828 1/20 0.44
NPC1 O15118 1/20 0.44
MAPK14 Q16539 1/20 0.44
KDM4E B2RXH2 1/20 0.43
RAF1 P04049 1/20 0.43
BRAF P15056 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
PIK3CA P42336 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5126561 0.80 ALDH1A1 (0.47) DGAT1GAAALDH1A1HPGDCYP1A2
SCHEMBL5027375 0.79 NPC1 (0.55) DGAT1GAAALDH1A1HPGDMAPT
SCHEMBL13588594 0.77 JAK2 (0.72) FLT1KDRJAK2JAK3
SCHEMBL5033875 0.76 MCL1 (0.40) GAAALDH1A1HPGDCYP1A2MAPT
SCHEMBL5052668 0.72 ADORA3 (0.50) ALDH1A1HPGDMAPTSMN1; SMN2RAB9A
SCHEMBL12661996 0.71 PARP1 (0.41) GAAALDH1A1HPGDCYP1A2KDR
SCHEMBL14360826 0.70 TYK2 (0.46) MAPTSMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL5032088 0.69 MCL1 (0.41) GAAALDH1A1MAPTSMN1; SMN2RAB9A
SCHEMBL2891693 0.69 TYK2 (0.41) CYP1A2RAB9ANPC1KDM4E
SCHEMBL5029502 0.69 CYP11B2 (0.46) CYP1A2IRAK4MAPTKDRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1983831-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2008-10-29 EP claimed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US claimed
WO-2007087429-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO claimed
EP-1983831-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2008-10-29 EP disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
WO-2007087429-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses NLRP3, CCR1, NLRP1 DGAT1 4685/4885GAA 1129/4885ALDH1A1 2389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.